Meet the CEO: Dr. Pablo Escribá
“If someone has done it before, I can do it too – if no one has done it, I can be the first”: for 30...
23 March, 2021-
Next generation medicinesLearn moreWe design and develop drugs based on a novel therapeutic approach called melitherapy. -
A new pharmaceutical perspectiveLearn moreOur drugs are first-in-class molecules which target membrane lipids, instead of acting directly on proteins or DNA like other medicines.
-
Committed
to peopleLearn moreOur goal is to deliver reference treatments for illnesses with unmet medical needs, such as cancer and Alzheimer’s disease.
